Related Experiment Video

Updated: Jul 17, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy

Doron Ginsberg1

  • 1Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat Gan 52900, Israel. ginsbed@mail.biu.ac.il

Science'S STKE : Signal Transduction Knowledge Environment
|February 1, 2007
PubMed

Insights

Epidermal growth factor receptor (EGFR) signaling and the retinoblastoma tumor suppressor (RB) protein work together to prevent E2F1-induced cell death. This suggests new targeted cancer therapies for tumors with inactive RB.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The retinoblastoma tumor suppressor (RB) protein controls cell proliferation by regulating E2F transcription factors.
  • Inactivation of RB in human tumors leads to uncontrolled cell growth.
  • E2F1, an E2F protein, can induce apoptosis, but cellular sensitivity varies.
  • Factors determining E2F1-induced apoptosis sensitivity in vivo were previously unknown.

Purpose of the Study:

  • To identify variables influencing cellular sensitivity to E2F1-induced apoptosis in vivo.
  • To investigate the role of epidermal growth factor receptor (EGFR) signaling in E2F1-induced apoptosis.
  • To explore the interaction between RB and EGFR signaling in apoptosis regulation.

Main Methods:

  • Utilized in vivo models to study apoptosis.
  • Investigated the interplay between RB, E2F1, and EGFR signaling pathways.
  • Assessed cellular sensitivity to E2F1-induced apoptosis under varying EGFR signaling conditions.

Main Results:

  • Epidermal growth factor receptor (EGFR) signaling was identified as a key variable in E2F1-induced apoptosis.
  • EGFR signaling cooperates with the retinoblastoma tumor suppressor (RB) protein to inhibit E2F1-induced apoptosis.
  • This cooperative inhibition suggests a mechanism for controlling cell death in response to RB status.

Conclusions:

  • EGFR signaling is a critical determinant of cellular sensitivity to E2F1-induced apoptosis.
  • The interaction between RB and EGFR signaling provides a novel insight into apoptosis regulation.
  • Targeting EGFR signaling may offer a strategy to selectively induce apoptosis in cancer cells with inactivated RB, enabling targeted cancer therapies.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...